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Abstract To investigate the DNA regulatory sequences re-
quired for stimulation and suppression of leptin gene expression,
primary cultured hepatocytes and adipocytes of rats were
transfected with plasmids containing the 5P-flanking sequences
of the rat leptin gene fused to the luciferase gene. When two
copies of the sequences spanning nucleotides 3101 to 383 of the
leptin promoter were used for transfection, the reporter activity
significantly increased in the presence of glucose/insulin in
comparison with glucose alone. The glucose/insulin stimulation
of the transcription was inhibited by addition of polyunsaturated
fatty acids. These results were similar to those found earlier for
the transcription of the fatty acid synthase, FAS(357/335) and
ATP citrate-lyase, ACL(364/341) genes. Cotransfection stu-
dies in the cells with a Sp1 expression vector and leptin (3101/
383) constructs showed the inactivation of the leptin promoter
by Sp1. Gel mobility shift assays using an end-labeled
leptin(3101/383) construct as a probe revealed that nuclear
factor(s) from rat liver or adipose tissue specifically formed
complexes with the sequence. The DNA-protein complexes were
common to the glucose/insulin-responsive regions of the leptin,
ACL and FAS genes, suggesting that these genes are coordi-
nately regulated. In addition, by antibody supershift assays, the
transcription factor Sp1 was found to bind the GC-rich region
located between nucleotides 3101 and 383 of the leptin gene.
Mutational analysis of this region showed that the sequence of
the region was critical for glucose/insulin stimulation of
transcription. Thus, we postulated that the region from 3101
to 383 of the leptin gene is responsible for glucose/insulin
stimulation of transcription, and that Sp1 is somehow involved in
this regulation.
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1. Introduction
Leptin is a hormone produced in adipose cells that is im-
portant in the regulation of energy expenditure, food intake
and adiposity [1,2]. Leptin expression is regulated by gluco-
corticoids [3,4], insulin [5,6], L-adrenergic agonist [3], thiozo-
lidinediones [7^9] and fasting [10,11]. Sp1 has been shown to
be a transcription factor of leptin gene expression, binding to
nucleotides 3101 to 383, and mutation in this region abol-
ishes transcription factor binding and reduces promoter activ-
ity [12].
We previously mapped the sequences responsible to glu-
cose/insulin stimulation in the proximal promoter region
from 357 to 335 of fatty acid synthase (FAS) (EC 2.3.1.85)
and 364 to 341 of ATP citrate lyase (ACL) (EC 4.1.3.8) of
rat liver [13,14]. When two copies of a synthetic nucleotide
probe of region 357 to 335 of the FAS gene were linked to a
reporter gene and the resultant construct was used for trans-
fection, the reporter gene activity was signi¢cantly increased
in hepatocytes in response to glucose/insulin treatment and
the insulin stimulation was suppressed by polyunsaturated
fatty acid (PUFA), Sp1 and leptin [15]. The same results
were observed with the 364 to 341 region of the ACL gene
[16]. Nucleotides 3101 to 383 of the leptin gene, 357 to 335
of the FAS gene and 364 to 341 of the ACL gene contain
overlapping binding sites for Sp1 proteins [12,15,16]. It is thus
possible that nucleotides 3101 to 383 of leptin may be a
glucose/insulin response element and Sp1 may be involved in
the transcriptional regulation. Recent work in cultured adi-
pose cells [17,18] and hepatocytes [19] has suggested that lep-
tin may antagonize insulin action in these cells. In the present
study, in order to make clear these possibilities, we have in-
vestigated the e¡ects of glucose/insulin and PUFA on the
transcription of the leptin gene, using leptin(3101/383) linked
to a reporter gene in primary cultured hepatocytes and adi-
pocytes of rats.
2. Materials and methods
2.1. Materials
Restriction endonucleases, other enzymes and a sequencing kit were
purchased from Takara Shuzo (Kyoto). The PGL3 promoter vector
and dual luciferase assay system were purchased from Promega (Hei-
delberg). The luciferase assay kit was from Toyo Ink (Tokyo). Wil-
liams’ medium E was purchased from Flow Laboratories (Costa
Mesa, CA) and other culture media from Nissui Seiyaku (Tokyo).
[14C]Chloramphenicol (2.22 GBq/mmol) and [Q-32P]ATP (110 GBq/
mmol) were from ICN (Costa, CA). Antibodies against Sp1 and
Sp3 were obtained from Santa Cruz Biotec (Santa Cruz, CA),
lipofectin reagent from Life Technologies (Palo Alto, CA) and
recombinant mouse leptin from RpD Systems Inc. (Minneapolis,
MN).
2.2. Plasmid constructs
Plasmid pactL, a luciferase vector containing L-actin enhancer and
promoter, and PRL-SV40 were used as an internal control to normal-
ize for variations in chloramphenicol acetyltransferase (CAT) and
luciferase transfection e⁄ciency [20]. Plasmid PL1cat, which contains
a fragment spanning 394 to +37 of the L-type pyruvate kinase (LPK)
gene, was produced from LPKcat [21]. Plasmid pRSVSp1 [22] was a
generous gift from Prof. Y. Fujii-Kuriyama (Touhoku University,
Japan). Plasmid pRCMVSp3 [23] was a generous gift from
Prof. G. Suske (Philipps Universita«t Marburg). The following single-
stranded oligonucleotides were synthesized by Gibco Ltd (Grand
Island, NY).
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Leptin(3101/383): 5P-AGCTGGGGCGGGAGTTGGCGCTC-3P
Leptin(3101/383)M: 5P-AGCTGAAGCTTGAGTTGGCGCTC-3P
FAS(357/335): 5P-GATCGTGGCCGCGCGGGGATGGCC-
GCG-3P
ACL(364/341): 5P-GATCTGATGGGGGGCGGGGAGGAG-
CCCG-3P
Sp1: 5P-ATTCGATCGGGGCGGGGCGAGC-3P
Underlined sequences are mutations consisting of substituted bases.
Double-stranded oligonucleotides of leptin(3101/383) or leptin
(-101/-83)M were inserted into the PGL3 promoter. Double-stranded
oligonucleotides of FAS(357/335) were inserted into the BamHI sites
of PL1cat [15]. The sequence of these inserts was veri¢ed by dideoxy
sequencing, using a sequencing kit [24]. Two copies of these sequences
were linked to the reporter gene.
2.3. Primary cell culture and transfection
Male Wistar rats (200^250 g) maintained on a standard diet (Ori-
ental Koubo, MF, Tokyo) were fasted for 16 h before experiments.
The rat hepatocytes and adipocytes were isolated by collagenase di-
gestion, and the DNA reporter constructs were transfected into the
cells, as described previously [25]. Subsequently, the cells were cul-
tured for 48 h in experimental medium (with 100 Wg/ml streptomycin
and 100 U/ml penicillin) containing 20 mM glucose with or without
0.1 WM insulin. To some cultures, 0.1 mM arachidonic acid or 0.3 WM
recombinant mouse leptin was added. All transfections were per-
formed at least three times in duplicate.
2.4. Reporter gene assay
The cells were incubated for 48 h after transfection, harvested and
lysed by sonication. The extracts were heated at 60‡C for 10 min to
inactivate endogenous acetylase [26,27]. Prior to the heating step,
aliquots were removed for luciferase assays [28]. The heated extracts
were centrifuged and the supernatants were assayed for CAT activ-
ities. Amounts of the cell extracts normalized by the luciferase activity
were used for CAT assays, and the acetylated and non-acetylated
forms of [14C]chloramphenicol were determined using a scintillation
counter. The percentages of the acetylated forms were calculated. The
luciferase reporter activity was assayed by the dual luciferase assay
system from Promega according to the manufacturer’s instructions
and measured with a Turner Design TD-20/20 luminometer [29].
The luciferase activity driven by the 3101 to 383 region of the leptin
promoter was expressed as a percentage of the SV40 promoter-driven
luciferase activity, which served as a positive control in every trans-
fection experiment.
2.5. Gel mobility shift assay
Nuclear extracts from rat livers and adipocytes were prepared as
described by Gorski et al. [30]. The end-labeled double-stranded oli-
gonucleotide corresponding to leptin nucleotides 3101/383 was incu-
bated with the indicated amount of nuclear proteins as described
previously [15]. The reaction mixture was incubated for 1 h at room
temperature and then loaded onto a 4% non-denaturing polyacryl-
amide gel and separated by electrophoresis at 200 V for 1 h [21]. In
competition studies, the indicated amounts of double-stranded oligo-
nucleotide were added to the reaction mixtures. The nucleotide se-
quences of FAS(357/335) [15], ACL(364/341) [16] and Sp1 [31]
are shown above. For antibody supershift assays, Sp1 or Sp3 antibody
was added to the binding reaction mixture and incubated for 1 h at
room temperature prior to adding the labeled probes. The gel was
then ¢xed in 10% methanol/10% acetic acid, dried, and autoradio-
graphed.
3. Results and discussion
3.1. E¡ects of glucose/insulin, PUFA, Sp1 family and leptin on
leptin transcription
To explore possible regulatory elements in the 5P-£anking
region of the leptin gene, double-stranded oligonucleotides
corresponding to nucleotides 3101 to 383 of the leptin
gene were synthesized and linked the PGL3 promoter. The
plasmid DNA was then transfected into rat hepatocytes and
adipocytes. The cells were cultured in the presence of glucose
with or without insulin for 48 h, and then used to prepare
extracts which were assayed for luciferase activity, as a report-
er activity for leptin transcription. As shown in Table 1A, in
the presence of glucose/insulin, the reporter activity of leptin
gene transcription was markedly increased (by 1.5-fold) above
that in the presence of glucose alone in rat hepatocytes. The
stimulation by glucose/insulin was reduced by 44% in arach-
idonic acid-treated hepatocytes and by 36% in leptin-treated
hepatocytes. In adipocytes, the reporter activity was also
stimulated by glucose/insulin and suppressed by PUFA or
leptin, although the degrees of stimulation and suppression
were smaller than in hepatocytes.
To test the binding of Sp1 to the DNA, rat hepatocytes and
adipocytes were cotransfected with the leptin gene region
(3101/383) linked to a reporter gene (PGL3 promoter) and
the Sp1 expression vector. The leptin gene reporter activity
was reduced in the presence of the Sp1 expression vector. It
is suggested that Sp1 can bind to the Sp1 consensus sequence
located between nucleotides 3101 and 383 of the leptin gene,
and that the bound Sp1 inactivates transcription. To further
de¢ne the sequence involved in the glucose/insulin responsive-
ness of the leptin promoter, mutagenesis was performed in the
region from 3100 to 395 of the leptin gene. The mutation
resulted in a loss of responsiveness to glucose/insulin (data not
shown). The leptin gene reporter activity was not signi¢cantly
changed in the presence of the Sp3 expression vector.
As a positive control, the transcriptional activities of
FAS(357/335) linked to PL1cat or ACL(364/341) linked
to ACLcat20 were measured in the same hepatocytes and
adipocytes used for leptin transcription studies. The transcrip-
tional activities of the FAS and ACL genes were stimulated
by glucose/insulin, and the stimulation was suppressed by
Table 1
E¡ects of glucose/insulin, PUFA, leptin and Sp1 family on tran-
scriptional activities of leptin gene and fatty acid synthase gene
Hepatocytes Adipocytes
(A) Relative reporter activity of Leptin(3101/383)
Glu 0.69 þ 0.06b 0.47 þ 0.03c
Glu+In 1.00 þ 0.09a 0.87 þ 0.05a
Glu+In+20:4 0.56 þ 0.20b;c 0.65 þ 0.04b
Glu+In+leptin 0.64 þ 0.13b 0.73 þ 0.06b
Glu+In+Sp1 vector 0.65 þ 0.16b 0.58 þ 0.08b;c
Glu+In+Sp3 vector 0.86 þ 0.12a;b 0.86 þ 0.12a;b
(B) Relative reporter activity of FAS(357/335)
Glu 0.35 þ 0.04c 0.39 þ 0.04c
Glu+In 1.00 þ 0.12a 0.63 þ 0.09b
Glu+In+20:4 0.28 þ 0.10c 0.43 þ 0.05c
Glu+In+leptin 0.53 þ 0.17b;c 0.39 þ 0.15c
A: The plasmid construct containing leptin(3101/383) linked to
PGL3 promoter was introduced into primary cultured hepatocytes
and adipocytes. The cells were cultured for 48 h to measure the re-
porter activities in Williams’ E medium containing 20 mM glucose
(Glu) with or without 0.1 WM insulin (In). When included, 0.1 mM
arachidonic acid (20:4) or 0.3 WM leptin was added. To some cul-
tures, leptin(3101/383) linked to PGL3 promoter was cotransfected
into cells with or without the Sp1 or Sp3 expression vector. B: The
construct of FAS(357/335) linked to PL1cat was introduced into
the same cells as used for A. The percentages of acetylated forms of
[14C]chloramphenicol were determined as the CAT activities for
each sample. In A and B, the relative reporter activities are normal-
ized to Glu+In in hepatocytes. Means with di¡erent superscript let-
ters in each item are signi¢cantly di¡erent at P6 0.05 (by ANOVA).
Means þ S.D. of four experiments are shown.
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PUFA or leptin in a manner similar to the leptin gene. The
results for FAS transcription are shown in Table 1B, and the
results for the ACL gene were very similar (data not shown).
These results con¢rmed those of previous studies [15,16]. The
transcriptional activities of the FAS and ACL genes stimu-
lated by glucose/insulin were suppressed in the presence of
Sp1 expression vector [15,16]. Leptin(3101/383), FAS(357/
335) and ACL(364/341) contain similar GC-rich sequences
in which an Sp1 consensus sequence is found.
3.2. Gel mobility shift assays
To identify and characterize potential protein-binding ac-
tivity associated with the leptin(3101/383) region, an electro-
phoretic mobility shift assay was used. End-labeled oligonu-
cleotide leptin(3101/383) was incubated with nuclear extracts
of rat liver and subjected to non-denaturing polyacrylamide
gel electrophoresis. Three bands of DNA-protein complexes
were observed and the formation of these complexes was com-
peted against by increasing amounts of unlabeled leptin(3101/
383) oligonucleotide (Fig. 1A). These results demonstrated
the speci¢city of the DNA-protein complex formation. In
the presence of excess unlabeled leptin(3101/383)M (mutated
oligonucleotide), no competition was observed (Fig. 1B). This
suggests that sequences between 3101 and 383 of the leptin
gene are essential for the binding of nuclear factor(s) to this
putative glucose/insulin response region.
The similarities between nucleotides 354 to 343 of FAS
and 360 to 349 of ACL were 9 out of 12, those between
nucleotides 351 to 340 of FAS and 3100 to 389 of leptin
were 8 out of 12 and those between nucleotides 358 to 351 of
ACL and 3101 to 394 of leptin were 8 out of 8. Therefore,
we tested whether these FAS and ACL sequences could com-
pete for the nuclear factors binding to leptin(3101/383). As
shown in Fig. 1A, FAS(357/335) and ACL(364/341) oligo-
nucleotides as well as leptin(3101/383) itself could e¡ectively
compete against the formation of the three bands of DNA-
protein complexes at 10- and 20-fold molar excess relative to
the labeled leptin probe. Leptin(3101/383), FAS(357/335)
and ACL (364/341) contain GC-rich sequences in which a
Sp1 consensus sequence is found. Addition of a given amount
of Sp1 probe to the gel mobility shift reactions e¡ectively
competed against the labeled leptin probe (Fig. 1A). These
results suggested that Sp1 can bind to the glucose/insulin re-
sponse elements of leptin(3101/383) as well as to those of
FAS(357/335) and ACL(364/341).
The results for nuclear extracts of adipose tissue are shown
in Fig. 2. Only one band of DNA-protein complex (band 3)
was seen in the £uorogram. Addition of Sp1 probe to the gel
mobility shift reactions competed against the labeled leptin
probe, although the competition was not as strong as in the
liver nuclear extracts. After incubation of nuclear extracts
of adipose tissue with the leptin probe in the presence of
Sp1 antibody, the supershift band disappeared (Fig. 3).
Therefore, any other binding protein than Sp1 may exist for
DNA-protein complex formation in adipose tissue. The
physiological signi¢cance of these ¢ndings awaits further in-
vestigation.
Since Sp1 and other related proteins, particularly Sp3, are
known to bind to the Sp1 consensus sequence, we attempted
to further demonstrate binding of the Sp1 family to the leptin
gene. After incubation of nuclear extracts with the leptin
probe in the presence of Sp1 antibody, band 1, band 2 and
band 3 were supershifted, as shown in Fig. 3. The formation
Fig. 2. Gel mobility shift assays using adipose tissue nuclear extracts
with end-labeled leptin(3101/-83). Increasing amounts of rat adipose
tissue nuclear extracts were incubated in the presence of end-labeled
oligonucleotide leptin(3101/383). Competitor DNA was added in
10-fold molar excess relative to labeled DNA. The species of com-
petitor DNAs are indicated at the top. L: leptin(3101/383), LM:
mutant leptin(3101/383), ACL: ACL(364/341), FAS: FAS(357/
335).
Fig. 1. Gel mobility shift assays using liver nuclear extracts with end-labeled leptin(3101/383). Increasing amounts of rat liver nuclear extracts
were incubated in the presence of end-labeled oligonucleotide leptin(3101/383) and then loaded onto a 4% non-denaturing polyacrylamide gel.
A: Competitor DNA [leptin(3101/383), Sp1, ACL(364/341) or FAS(357/335)] was added in 10- and 20-fold molar excess relative to labeled
DNA. B: Competitor DNA [leptin(3101/383) or mutant leptin(3101/383)] was added in 10- and 20-fold molar excess relative to labeled
DNA. The species and molar ratios of competitor DNAs are indicated at the top.
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of band 1 and band 2 was e⁄ciently inhibited in the presence
of Sp3 antibody. These results show that band 1 and band 2
represent speci¢c leptin(3101/383)-containing protein-DNA
complex(es) which contain Sp3 and Sp1. Band 3 represents
speci¢c leptin(3101/383)-protein-DNA complex(es) which
contain Sp1 but not Sp3. It has been reported that the glucose
activation of acetyl-CoA carboxylase gene promoter II was
mediated by a member of the Sp1 family of transcription
factors [32], and moreover, Sp1, Sp3 and Sp4 have similar
structural characteristics and identical DNA binding speci¢c-
ities [33,34].
Daniel and Kim [32] reported that promoter II of the ace-
tyl-CoA carboxylase gene (3340 to 3249) was activated by
high concentrations of glucose, and that the e¡ects of glucose
were mediated by Sp1. On the other hand, Rolland et al. [35]
reported that FAS promoter activity mainly depended on a
region from 3200 to 3126, and this sequence exerted a strong
negative e¡ect on the FAS promoter in adipocytes from lean
rats but not in those from obese rats. They demonstrated that
Sp1 or Sp1-like proteins were bound to this DNA subregion.
The present studies demonstrated that Sp1 and Sp3 can
bind to the sequences located between 3101 and 383 of the
leptin gene, and that the bound Sp1 inactivated the leptin
transcription. Similarly, Sp1 and Sp3 bound to nucleotides
357 to 335 of the FAS gene and nucleotides 364 to 341
of the ACL gene, and the binding of Sp1 inactivated the tran-
scription of the FAS(357/335) and ACL(364/341) genes
whereas the binding of Sp3 stimulated the transcription of
these genes (Fukuda et al., unpublished results). However,
the binding of Sp3 did not stimulate the transcription of genes
controlled by the leptin(3101/383) region in the present ex-
periments. Moreover, these three nucleotide regions have been
postulated to be the response elements of glucose/insulin acti-
vation which are inactivated by PUFA, Sp1 or leptin. Thus,
we postulated that Sp1 and Sp3 are somehow involved
in the glucose/insulin activation and the PUFA or
leptin inactivation of the leptin gene as well as the FAS and
ACL genes, suggesting that these genes are coordinately
regulated.
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